Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia

A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®

NCT00884689 ·Status: COMPLETED

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT01647646 ·Status: COMPLETED ·Phase: PHASE4

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

NCT00319306 ·Status: COMPLETED ·Phase: PHASE3

A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®

NCT00532922 ·Status: COMPLETED

Local Phase 4 Pan-European SMART Study

NCT00463866 ·Status: COMPLETED ·Phase: PHASE4

NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART

NCT00785733 ·Status: COMPLETED

Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler

NCT00524641 ·Status: COMPLETED

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

NCT01711840 ·Status: COMPLETED

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT00784953 ·Status: COMPLETED

A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice

NCT00505388 ·Status: COMPLETED

Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)

NCT00937066 ·Status: COMPLETED

NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler

NCT00557297 ·Status: COMPLETED

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

NCT00837967 ·Status: COMPLETED ·Phase: PHASE3

STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma

NCT00252824 ·Status: COMPLETED ·Phase: PHASE3

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

NCT00255255 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00385593 ·Status: TERMINATED ·Phase: PHASE3

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739 ·Status: COMPLETED ·Phase: PHASE4

A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

NCT00858286 ·Status: COMPLETED ·Phase: PHASE4

A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART

NCT00503061 ·Status: COMPLETED

Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

NCT00782314 ·Status: COMPLETED

New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day

NCT01360021 ·Status: COMPLETED ·Phase: PHASE3

Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler

NCT00812682 ·Status: COMPLETED

Symbicort Rapihaler Therapeutic Equivalence Study

NCT00536731 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma

NCT01099722 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma

NCT00628758 ·Status: COMPLETED ·Phase: PHASE3